Regeneration and bioengineering of the kidney: current status and future challenges
Related Experiment Video
Updated: May 4, 2026

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
Published on: August 10, 2015
Marcus Salvatori1, Andrea Peloso, Ravi Katari
1Oxford University Hospitals NHS Trust, Oxford, UK.
Abstract:
The prevalence of chronic kidney disease continues to outpace the development of effective treatment strategies. For patients with advanced disease, renal replacement therapies approximate the filtration functions of the kidney at considerable cost and inconvenience, while failing to restore the resorptive and endocrine functions. Allogeneic transplantation remains the only restorative treatment, but donor shortage, surgical morbidity and the need for lifelong immunosuppression significantly limit clinical application. Emerging technologies in the fields of regenerative medicine and tissue engineering strive to address these limitations. We review recent advances in cell-based therapies, primordial allografts, bio-artificial organs and whole-organ bioengineering as they apply to renal regeneration. Collaborative efforts across these fields aim to produce a bioengineered kidney capable of restoring renal function in patients with end-stage disease.
Insights
Chronic kidney disease treatments are limited. Regenerative medicine and tissue engineering offer new hope for bioengineered kidneys to restore function in end-stage renal disease patients.
Area of Science:
- Regenerative medicine
- Tissue engineering
- Nephrology
Background:
- Chronic kidney disease (CKD) prevalence is rising, exceeding current treatment capabilities.
- Existing renal replacement therapies (e.g., dialysis, transplantation) have significant limitations, including cost, inconvenience, donor shortage, and immunosuppression requirements.
- Current treatments fail to fully restore kidney resorptive and endocrine functions.
Purpose of the Study:
- To review recent advances in regenerative medicine and tissue engineering for renal regeneration.
- To explore novel approaches for developing functional bioengineered kidneys.
- To address the limitations of current treatments for end-stage renal disease.
Main Methods:
- Review of emerging technologies in cell-based therapies.
- Examination of primordial allografts for kidney regeneration.
- Analysis of bio-artificial organs and whole-organ bioengineering techniques.
- Assessment of progress in renal regeneration strategies.
Main Results:
- Significant advancements have been made in cell-based therapies and bioengineering approaches for kidney regeneration.
- Novel strategies such as primordial allografts and bio-artificial organs show promise.
- Collaborative efforts are accelerating the development of bioengineered kidneys.
Conclusions:
- Regenerative medicine and tissue engineering hold significant potential for treating end-stage renal disease.
- Bioengineered kidneys aim to overcome the limitations of current renal replacement therapies.
- Future collaborative research endeavors are crucial for realizing functional bioengineered kidneys.
Related Concept Videos
Kidney Transplant I: Introduction
Physiology of the Genitourinary System I: Renal Blood Flow and Glomerular Filtration
Whole Body Regeneration
Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction

